“One-pot” sequential preparation of isoquinoline-1,3(2H,4H)-dione derivatives by reacting N-alkyl(aryl)-N-methacryloyl benzamides with benzyl alcohols and sodium benzenesulfinates
-
Add time:07/15/2019 Source:sciencedirect.com
Two cascade coupling reactions were developed between N-alkyl(aryl)-N-methacryloyl benzamides and readily available benzyl alcohols or sodium benzenesulfinates. Through a radical cyclization strategy, these one-pot sequential reactions provided two simple and efficient approaches to the synthesis of a variety of isoquinoline-1,3(2H,4H)-dione derivatives in high yields with a broad substrate scope. These compounds are valuable molecules in drug discovery.
We also recommend Trading Suppliers and Manufacturers of Benzamide, 4-ethyl-N-(1-phenylethyl)- (cas 116368-37-7). Pls Click Website Link as below: cas 116368-37-7 suppliers
Prev:Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides
Next:Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists07/17/2019
- Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus07/16/2019
- Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides07/14/2019
- Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides07/13/2019
- Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands07/12/2019
- Microbial deracemisation of N-(1-hydroxy-1-phenylethyl)benzamide07/11/2019


